After Patent Ruling, Availability of Gene Tests Could Broaden
Friday, June 14, 2013 - 10:20
in Health & Medicine
The Supreme Court’s decision in effect ends a nearly two-decade monopoly by Myriad Genetics on genes that correlate with increased risk of some cancers.